Isolated mucocele of the posterior ethmoid cells is a relatively rare pathological condition, so the technical features of its surgical treatment have not been clearly de!ned. Traditional approaches to this region include opening all ethmoid cells and using general anesthesia as patient support. However, in patients with limitations regarding anesthesia, it may pose problems. The present paper discusses a clinical case of a posterior ethmoid cell mucocele that was drained by direct access medially from the middle turbinate, similar to access to the sphenoethmoidal recess. In addition, given the small amount of damage, it was decided to perform the operation under combined anesthesia, and image guidance was used for the speed and accuracy of the surgical approach. A direct endoscopic approach for isolated posterior ethmoid cell pathology can serve as an alternative to standard access. If it is necessary to open only the posterior ethmoid cell in patients with high risks of general anesthesia, an endoscopic approach through the middle turbinate can be used.
| Primary Language | English |
|---|---|
| Subjects | Allergy |
| Journal Section | Research Article |
| Authors | |
| Submission Date | September 23, 2024 |
| Acceptance Date | December 5, 2024 |
| Publication Date | April 20, 2025 |
| Published in Issue | Year 2025 Volume: 8 Issue: 1 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.